Mirae Asset Global Investments Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,333 shares of RARE stock, worth $149,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,333

Previous 2,482 34.29%

Holding current value

$149,151

Previous $102,000 81.37%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$40.21 - $59.36 $34,218 - $50,515	851 Added 34.29%	3,333 $185,000
Q2 2024 Jul 30, 2024	SELL	$37.42 - $51.61 $8.54 Million - $11.8 Million	-228,285 Reduced 98.92%	2,482 $102,000
Q1 2024 May 01, 2024	BUY	$43.02 - $53.69 $5.27 Million - $6.57 Million	122,412 Added 112.97%	230,767 $10.8 Million
Q4 2023 Jan 24, 2024	SELL	$31.73 - $49.19 $3.26 Million - $5.05 Million	-102,613 Reduced 48.64%	108,355 $5.18 Million
Q3 2023 Oct 26, 2023	BUY	$34.92 - $46.66 $658,067 - $879,307	18,845 Added 9.81%	210,968 $7.52 Million
Q2 2023 Aug 10, 2023	SELL	$37.35 - $52.15 $1.53 Million - $2.14 Million	-41,033 Reduced 17.6%	192,123 $8.86 Million
Q1 2023 May 04, 2023	BUY	$36.99 - $48.71 $313,638 - $413,012	8,479 Added 3.77%	233,156 $9.35 Million
Q4 2022 Feb 09, 2023	BUY	$33.72 - $46.33 $3.11 Million - $4.27 Million	92,185 Added 69.58%	224,677 $10.4 Million
Q3 2022 Nov 10, 2022	BUY	$39.96 - $66.14 $173,146 - $286,584	4,333 Added 3.38%	132,492 $5.49 Million
Q2 2022 Jul 26, 2022	SELL	$45.8 - $85.4 $400,612 - $746,993	-8,747 Reduced 6.39%	128,159 $7.65 Million
Q1 2022 May 10, 2022	SELL	$62.2 - $84.4 $1.48 Million - $2.01 Million	-23,821 Reduced 14.82%	136,906 $9.94 Million
Q4 2021 Feb 08, 2022	BUY	$73.71 - $87.86 $2.75 Million - $3.28 Million	37,320 Added 30.24%	160,727 $13.5 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $1.64 Million - $2.15 Million	21,012 Added 20.52%	123,407 $11.1 Million
Q2 2021 Aug 11, 2021	BUY	$92.19 - $115.71 $1.3 Million - $1.64 Million	14,134 Added 16.01%	102,395 $9.76 Million
Q1 2021 May 13, 2021	BUY	$106.9 - $167.73 $3.6 Million - $5.65 Million	33,663 Added 61.66%	88,261 $10 Million
Q4 2020 Feb 10, 2021	BUY	$84.4 - $177.39 $866,112 - $1.82 Million	10,262 Added 23.15%	54,598 $7.56 Million
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $926,189 - $1.14 Million	12,691 Added 40.1%	44,336 $3.64 Million
Q2 2020 Aug 11, 2020	BUY	$46.91 - $78.22 $488,004 - $813,722	10,403 Added 48.97%	31,645 $2.48 Million
Q1 2020 May 12, 2020	BUY	$33.8 - $62.9 $75,982 - $141,399	2,248 Added 11.84%	21,242 $943,000
Q4 2019 Feb 12, 2020	BUY	$36.08 - $45.83 $295,314 - $375,118	8,185 Added 75.72%	18,994 $811,000
Q3 2019 Nov 12, 2019	BUY	$42.5 - $63.11 $298,435 - $443,158	7,022 Added 185.42%	10,809 $463,000
Q2 2019 Aug 13, 2019	BUY	$54.93 - $74.36 $208,019 - $281,601	3,787 New	3,787 $241,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History